Boston Scientific Recalls Microcatheters in South Africa
The National Consumer Commission has issued a recall for specific microcatheter units due to potential manufacturing defects.
Updated on Oct. 20, 2026 in Heart Disease
Live Poll
Do you trust that medical device companies effectively inform patients and hospitals about safety recalls?
Boston Scientific has initiated a recall of 199 units of its Direxion and Direxion HI-FLO Torqueable Microcatheters across South Africa. The devices, used for accessing peripheral vasculature, are being pulled from inventory due to a manufacturing issue that can lead to hazardous resistance during use.
Why it matters
The recall is a precautionary measure because faulty catheters may sustain damage during operation, posing a remote risk of life-threatening embolism. Healthcare facilities are now required to identify and secure all affected units to prevent patient harm.
The recall encompasses 199 units of Direxion and Direxion HI-FLO Torqueable Microcatheters distributed nationwide. The full scope of the financial impact or the specific volume of devices remaining in use at non-named clinics remains under investigation.
The players
Boston Scientific
This is a global medical technology company that develops and manufactures products for use in various medical specialties, including interventional cardiology and peripheral interventions.
National Consumer Commission
This is the South African regulatory body responsible for protecting consumer rights and overseeing the enforcement of the Consumer Protection Act within the country.
Groote Schuur Hospital
This is a major public hospital located in Cape Town, South Africa, widely known for being the site of the world's first successful human-to-human heart transplant.
Life Healthcare
This is a major private hospital operator in South Africa that provides a wide range of acute care and diagnostic services to patients across the country.
The details
The manufacturing defect involves a failure in the catheter's carrier hoop that can cause increased resistance, potentially damaging the device while in use. Affected facilities, including Groote Schuur Hospital and Life Healthcare locations, must immediately isolate the units according to the supplier recall notice.
Timeline
20 October 2026: The recall was reported following safety concerns identified with the medical devices.
Health Landscape
This recall aligns with the rigorous safety standards mandated by the Consumer Protection Act to ensure that medical devices meeting the quality threshold are removed from circulation. It highlights the critical nature of post-market surveillance in the broader healthcare system.
Patients who have recently undergone or are scheduled for procedures involving vascular access should consult their medical providers regarding device safety. Facilities are tasked with ensuring that no defective units are utilised during ongoing or future clinical treatments.
The takeaway
Patients or family members concerned about recent procedures can request confirmation from their medical facility that these specific microcatheters were not involved in their care. Always verify that healthcare providers have implemented the required segregation protocols for recalled medical equipment.
Further reading
Learn more about the latest updates in Heart Disease management and safety protocols.
Live Poll
Do you trust that medical device companies effectively inform patients and hospitals about safety recalls?
